Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Accounts Payables (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Accounts Payables for 5 consecutive years, with $1.5 million as the latest value for Q3 2020.

  • Quarterly Accounts Payables fell 34.02% to $1.5 million in Q3 2020 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Sep 2020, down 34.02% year-over-year, with the annual reading at $1.6 million for FY2019, 53.91% down from the prior year.
  • Accounts Payables for Q3 2020 was $1.5 million at Forte Biosciences, down from $2.6 million in the prior quarter.
  • The five-year high for Accounts Payables was $4.6 million in Q3 2018, with the low at $947000.0 in Q1 2017.
  • Average Accounts Payables over 5 years is $2.1 million, with a median of $1.7 million recorded in 2016.
  • The sharpest move saw Accounts Payables soared 294.71% in 2018, then tumbled 53.91% in 2019.
  • Over 5 years, Accounts Payables stood at $1.7 million in 2016, then grew by 17.11% to $2.0 million in 2017, then surged by 74.47% to $3.4 million in 2018, then tumbled by 53.91% to $1.6 million in 2019, then fell by 3.57% to $1.5 million in 2020.
  • According to Business Quant data, Accounts Payables over the past three periods came in at $1.5 million, $2.6 million, and $1.6 million for Q3 2020, Q2 2020, and Q1 2020 respectively.